Enhanc3D Genomics

Enhanc3D Genomics is a functional data science biotechnology company whose platform, GenLink3D, aims to unlock the potential of 3D DNA organization. Enhanc3D's patented technology directly measures DNA interactions that control gene regulation, enabling exploration of the non-coding regions of DNA, which account for approximately 98% of the entire genome. Initially, the platform will generate large datasets for various immune cell types, which have broad relevance to autoimmune diseases, cancer, and aging.